Pulse Biosciences, Inc. (NASDAQ: PLSE) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $3.3B. The Maz Rating grades it against the other companies in its sector.
Pulse Biosciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $44.84, Pulse Biosciences, Inc. trades at 2188.9x sales and 17.4x book value. Over the last twelve months it generated about $2M of revenue and a net loss of $89M. It runs a gross margin of 9.4%, an operating margin of -5821.1% and a net margin of -5603.9%. It shows return on equity of -77.9%, return on invested capital of -45.8% and a free cash flow yield of -1.9%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 14.35. Over the past 52 weeks the share price ranged from $12.56 to $58.94, with a beta of 1.64.
Pulse Biosciences, Inc. does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 5 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.